Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00644423 · ClinicalTrials.gov registry record · NA
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)
A NA study, sponsored by Durham VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00644423 is a NA study that has completed, run by Durham VA Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT00644423, a NA study, has completed, sponsored by Durham VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
An increasing literature shows that omega-3 fatty acids provide numerous health benefits, including a variety of psychiatric symptoms and disorders including stress, anxiety, cognitive impairment, mood disorders (major depression and bipolar disorder) and schizophrenia. Omega-3 fatty acids may additionally represent a promising treatment strategy in patients with PTSD. Moreover, given its beneficial cardiovascular effects, adjunctive omega-3 fatty acids may also benefit the general health status of these veterans, who frequently present with a variety of comorbid medical disorders.
Interventions
- DRUG Placebo
- DRUG Omega-3 Fatty Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-09-22 |
| Est. Completion | 2010-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00644423
The ClinicalTrials.gov registry entry for NCT00644423 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Durham VA Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00644423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00644423 about?
NCT00644423 is a clinical study titled "Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)". An increasing literature shows that omega-3 fatty acids provide numerous health benefits, including a variety of psychiatric symptoms and disorders including stress, anxiety, cognitive impairment, mood disorders (major depression and bipolar disorder) and schizophrenia. Omega-3 fatty acids may addit...
What is the current status of trial NCT00644423?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2008-09-22. Estimated completion is 2010-07-15.
What interventions are being tested in trial NCT00644423?
The interventions under investigation include: Placebo (DRUG), Omega-3 Fatty Acid (DRUG).
Who is sponsoring clinical trial NCT00644423?
This trial is sponsored by Durham VA Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.